The chemical class known as WDR21A Activators encompasses a diverse range of compounds that can activate WDR21A through various biochemical mechanisms and cellular pathways. These activators are not unified by a common chemical structure or specific target interaction but are rather characterized by their ability to influence the cellular environment in a way that promotes the activity of WDR21A. They typically function by modulating the ubiquitin-proteasome system, a crucial cellular pathway responsible for the controlled degradation of proteins. By inhibiting the proteasome, these activators cause an accumulation of proteins within the cell, which can include substrates of WDR21A. This accumulation can lead to an increased demand for WDR21A function as the cell attempts to maintain protein homeostasis. In this way, the activators indirectly enhance the activity of WDR21A by increasing its substrate availability and its recognition and processing within the cell.
In addition to affecting proteasomal degradation, WDR21A Activators can also influence various cellular signaling pathways that intersect with the functional landscape of WDR21A. By altering the dynamics of specific signaling cascades, these chemicals can modulate the expression levels, localization, or interaction patterns of WDR21A, resulting in enhanced activity. This is achieved without directly binding to WDR21A or modifying its structure. Instead, the activators create a cellular context that is more conducive to WDR21A action, such as by inhibiting enzymes that regulate post-translational modifications on proteins that interact with WDR21A or by stabilizing proteins that facilitate the function of WDR21A. The versatility of these activators stems from their ability to target a range of processes, thereby broadening the scope of their impact on WDR21A activity beyond a single pathway or mechanism.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A boronic acid derivative that inhibits the 26S proteasome, leading to an accumulation of proteins that could be substrates for WDR21A, which could possibly activate WDR21A. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
A glutarimide that modulates the ubiquitin-proteasome system, and could affect WDR21A by altering the degradation of shared substrates, which could possibly activate WDR21A. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
A derivative of thalidomide that modulates the ubiquitin-proteasome system and has been shown to affect the function of specific CRLs, which could possibly activate WDR21A. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Similar to thalidomide and lenalidomide, it affects the ubiquitin-proteasome system and could possibly activate WDR21A by influencing its activity. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
A NEDD8-activating enzyme inhibitor that can prevent cullin neddylation, potentially affecting CUL4-WDR21A complex formation, which could possibly activate WDR21A. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound that can modulate various signaling pathways, and could possibly activate WDR21A by impacting its associated pathways. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
An isothiocyanate that can affect signaling pathways and the expression of various proteins, which could possibly activate WDR21A through altered signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenolic compound that can modulate signaling pathways and influence proteasomal degradation, which could possibly activate WDR21A. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
The main catechin in green tea, known to affect multiple signaling pathways and could possibly activate WDR21A by altering its regulatory environment. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
A steroidal lactone that can disrupt proteasomal function, which could possibly activate WDR21A by affecting its role in protein turnover. | ||||||